Olanzapine Tablet
Product Images NDC 67184-0563

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 67184-0563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

Olanzapine Tablets USP 2.5 mg oral tablets in a package containing 30 tablets. The label from Qilu Pharmaceutical Co., Ltd. includes medication instructions, storage information, and a barcode, along with NDC 67184-0561-1. The label also indicates it is a prescription-only drug.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

Olanzapine Tablets USP 5 mg tablet label from Qilu Pharmaceutical Co., Ltd. The label states the product contains 5 mg of olanzapine per tablet and comes in a 30-tablet package. It includes storage instructions to keep the tablets at controlled room temperature and to protect from light and moisture. The label also has a barcode and advises dispensing the accompanying Medication Guide to the patient.*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablets Bottle))

Olanzapine Tablets USP 7.5 mg oral tablets packaging label by Qilu Pharmaceutical Co., Ltd. The carton contains 30 tablets. Includes NDC 67184-0563-1 and storage instructions. The label advises keeping the bottle tightly closed and out of reach of children, with usual dosage instructions referring to accompanying literature.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 10 mg, oral tablets in a package of 30 tablets by Qilu Pharmaceutical Co., Ltd. Label includes dosage information, storage instructions to keep at 20° to 25°C (68° to 77°F) away from light and moisture, and cautions to keep out of reach of children. The label also features barcoding and lot number details.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

This label is for Olanzapine Tablets, USP, 15 mg, manufactured by Qilu Pharmaceutical Co., Ltd. It shows a 30-tablet package with instructions for pharmacists to dispense the accompanying medication guide. Storage and handling instructions include keeping the bottle tightly closed and storing at controlled room temperature. The label includes a barcode, NDC number 67184-0565-1, and fields for lot number, expiration date, and other tracking information.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 20 mg oral tablets in a package of 30 tablets. The label includes directions to dispense the accompanying Medication Guide, a warning to keep out of reach of children, and storage instructions to keep tightly closed and at controlled room temperature (20 to 25°C). Manufactured by Qilu Pharmaceutical Co., Ltd., China.*

FDA Label Image

Image Description (Olanzapine Str)

Chemical structure of olanzapine, showing its tricyclic ring system with nitrogen and sulfur atoms and methyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.